share_log

Applied DNA Sciences Shares Up 13% on Licensing Deal >APDN

道琼斯 ·  Jan 13, 2020 22:25

DJ Applied DNA Sciences Shares Up 13% on Licensing Deal >APDN



By Chris Wack



Applied DNA Sciences Inc. (APDN) shares rose 13% to $4.52 premarket after the company said its LineaRx Inc. subsidiary has signed a licensing agreement with LifeSensors Inc. to incorporate LifeSensors' high expression SUMO-fusion technologies into the company's linear DNA amplicons designed and produced for therapeutic applications.

Applied DNA said LineaRx will have a worldwide license to the applicable LifeSensors intellectual property to make, have made, use, and sell DNA constructs incorporating the SUMO-fusion technologies for therapeutic and diagnostic applications.

The companies said they will work together on initially developing and releasing two high expression amplicons: one for the generic Luciferase protein and one for its licensed anti-CD19 therapy.



Write to Chris Wack at chris.wack@wsj.com



(END) Dow Jones Newswires

January 13, 2020 09:25 ET (14:25 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment